Paul Varley is our Vice President of Chemistry, Manufacturing and Controls where he oversees our discovery and research and development process and management of manufacturing and testing.
Prior to joining Alchemab, Paul held similar roles at Kymab, Ltd., AstraZeneca/MedImmune and Cambridge Antibody Technology. Paul also worked at British Biotech, the UK National Institute of Biological Standards and Control (NIBSC) and the U.S. National Institutes of Health.
Paul is a former member of the British Pharmacopeia (BP) Commission and Chair of BP Expert Advisory Group on Biological and Biotechnological Products. He currently chairs a MHRA/BP Medicines working party on new standards for Biological Medicines (DPS) and is also a member of the European Pharmacopeia (EP) Expert Committee on Monoclonal Antibodies. Paul is also a member of the UK Vaccine Task Force/BIA Manufacturing Advisory Group.
Paul earned a PhD in Biochemistry from the University of Newcastle upon Tyne and a BSc degree in Biomolecular Sciences (First Class) from Portsmouth Polytechnic.